Clinical Trial Update: Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating upfront anthracycline chemotherapy followed by Nab-paclitaxel and trastuzumab for HER2-positive breast cancer, with the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anthracycline (anthracycline)
• Nab-paclitaxel (paclitaxel protein-bound)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Osaka Medical College | Conditions: Breast Cancer, HER-2 Positive Breast Cancer | Phase 2 | Status: COMPLETED